Isofol Medical AB
SEK0
0
+SEK0+0% Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
12NovExpected
Expected EPS
N/A
Actual EPS
N/A
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ISOFOL-BTA.ST. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Isofol Medical AB (publ) operates as a clinical stage biotech company. The company develops arfolitixorin, which is in phase Ib/II clinical trial for the treatment of metastatic colorectal cancer. Isofol Medical AB (publ) was incorporated in 2008 and is based in Gothenburg, Sweden.
Show more...
CEO
Mr. Petter Segelman Lindqvist
Employees
6
Country
DE
ISIN
SE0016074397
Listings
0 Comments
Share your thoughts
FAQ
What is Isofol Medical AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Isofol Medical AB stocks are traded under the ticker ISOFOL-BTA.ST.
How many employees does Isofol Medical AB have?▼
As of April 05, 2026, the company has 6 employees.
In which sector is Isofol Medical AB located?▼
Isofol Medical AB operates in the Health Care sector.
When did Isofol Medical AB complete a stock split?▼
Isofol Medical AB has not had any recent stock splits.
Where is Isofol Medical AB headquartered?▼
Isofol Medical AB is headquartered in Gothenburg, DE.